Tenax Therapeutics
TENX • NASDAQ
Tenax Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher T. Giordano, with a market cap of $256.2M.
CEOChristopher T. Giordano
Next Earnings
Upcoming earnings announcement for Tenax Therapeutics
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.40
Earnings History
Past 12 earnings reports for Tenax Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Q4 2025 | -$0.38Est: -$0.75 | +49.3% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.40Est: -$1.21 | +66.9% | - | — | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.27Est: -$0.47 | +42.6% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.28Est: -$0.41 | +31.7% | - | — | 10-Q |
| Mar 25, 2025 | Q4 2024 | -$0.18Est: -$0.42 | +57.1% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.19Est: -$1.39 | +86.3% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$1.83Est: -$1.98 | +7.6% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$3.12Est: -$2.40 | -30.0% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$11.84Est: -$8.14 | -45.5% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$6.40Est: -$8.00 | +20.0% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$4.00Est: -$8.00 | +50.0% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$12.00Est: -$29.60 | +59.5% | - | — | — |